General MedicationsORALGeneric
LORATADINE
LORATADINE
Standard Dose
1MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview LORATADINE is listed in Drugs@FDA under application 021734 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient LORATADINE Form and strength SUSPENSION;ORAL - 1MG/ML Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2005-10-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview LORATADINE is listed in Drugs@FDA under application 021734 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LORATADINE Form and strength SUSPENSION;ORAL - 1MG/ML Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2005-10-04 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.